These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3128572)

  • 21. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
    Keenan JA; Moghissi KS
    Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luteal support with both estradiol and progesterone after clomiphene citrate stimulation for in vitro fertilization.
    Hurd WW; Randolph JF; Christman GM; Ansbacher R; Menge AC; Gell JS
    Fertil Steril; 1996 Oct; 66(4):587-92. PubMed ID: 8816621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A short course of menotropin after clomiphene failure in infertile women with luteal phase defects.
    Wu CH
    J Reprod Med; 1989 Oct; 34(10):807-10. PubMed ID: 2507780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does progesterone supplementation improve pregnancy rates in clomiphene citrate and intrauterine insemination treatment cycles?
    Elguero S; Wyman A; Hurd WW; Barker N; Patel B; Liu JH
    Gynecol Endocrinol; 2015 Mar; 31(3):229-32. PubMed ID: 25430734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
    Tippet PD; Simon JA; Rifka SM; Falk RJ
    Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme.
    Smith EM; Anthony FW; Gadd SC; Masson GM
    BMJ; 1989 Jun; 298(6686):1483-6. PubMed ID: 2503080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of luteal support with human chorionic gonadotrophin or progesterone on the daily progesterone profile after different types of ovarian stimulation.
    Nikkanen V; Kresanov I; Mäkinen J; Vuorento T
    Hum Reprod; 1992 Mar; 7(3):333-6. PubMed ID: 1587937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles.
    Simon C; Oberyé J; Bellver J; Vidal C; Bosch E; Horcajadas JA; Murphy C; Adams S; Riesewijk A; Mannaerts B; Pellicer A
    Hum Reprod; 2005 Dec; 20(12):3318-27. PubMed ID: 16085660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Support of the luteal phase in in vitro fertilization programs: results of a controlled trial with intramuscular Proluton.
    Leeton J; Trounson A; Jessup D
    J In Vitro Fert Embryo Transf; 1985 Sep; 2(3):166-9. PubMed ID: 3932570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis.
    Gelbaya TA; Kyrgiou M; Tsoumpou I; Nardo LG
    Fertil Steril; 2008 Dec; 90(6):2116-25. PubMed ID: 18178194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response.
    Li Y; Yang W; Chen X; Li L; Zhang Q; Yang D
    Gynecol Endocrinol; 2016; 32(1):74-7. PubMed ID: 26370530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midluteal buserelin is superior to early follicular phase buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization.
    Urbancsek J; Witthaus E
    Fertil Steril; 1996 May; 65(5):966-71. PubMed ID: 8612858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen-thawed embryo transfer cycles.
    Kyrou D; Fatemi HM; Popovic-Todorovic B; Van den Abbeel E; Camus M; Devroey P
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):175-9. PubMed ID: 20219279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of luteal supplement on pregnancy outcome following stimulated IVF cycles.
    Tay PY; Lenton EA
    Med J Malaysia; 2005 Jun; 60(2):151-7. PubMed ID: 16114155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum inhibin levels in gonadotrophin stimulated in-vitro fertilization/gamete intra-fallopian transfer cycles.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Klinga K; Papp Z; Runnebaum B
    Hum Reprod; 1992 Oct; 7(9):1195-200. PubMed ID: 1478996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.